avanafil

Known as: (S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide, 4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide 
An orally available phosphodiesterase type 5 (PDE5) inhibitor with vasodilatory activity. Avanafil selectively inhibits PDE5, thus inhibiting the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2018
05101520082018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
PURPOSE We evaluated the safety and efficacy of 100 and 200 mg avanafil for the treatment of adult males with erectile… (More)
Is this relevant?
2013
2013
Orally active, selective inhibitors of phosphodiesterase type 5 (PDE 5, cyclic GMP PDE), such as sildenafil, tadalafil and… (More)
Is this relevant?
2013
2013
Ion mobility spectrometry was used as a rapid screening tool for the detection of acetildenafils, sildenafils and avanafil within… (More)
Is this relevant?
2013
2013
A Phase I, double-blind, randomized, crossover study in healthy males (N=106) was conducted between March 21, 2004, and May 17… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2013
2013
AIM Determine the long-term efficacy, safety and tolerability of avanafil, a highly specific, rapidly absorbed phosphodiesterase… (More)
Is this relevant?
2012
2012
INTRODUCTION Phosphodiesterase type 5 (PDE5) inhibitors have become standard treatment for erectile dysfunction (ED). AIM To… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • table 3
Is this relevant?
2012
2012
PURPOSE We investigated the in vitro inhibitory effects of avanafil, a novel, potent inhibitor of phosphodiesterase-5, on 11… (More)
Is this relevant?
2012
2012
OBJECTIVE To prospectively assess the safety and effectiveness of the investigational phosphodiesterase 5 inhibitor avanafil to… (More)
Is this relevant?
2012
2012
UNLABELLED Study Type--Therapy (RCT) Level of Evidence 1b. What's known on the subject? and What does the study add? Avanafil is… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • table 2
Is this relevant?
2010
2010
BACKGROUND Avanafil is a selective phosphodiesterase type 5 inhibitor being developed for the treatment of erectile dysfunction… (More)
Is this relevant?